When Lincoln Hibbard was born last spring with birth defects that kept him in neonatal intensive care for 53 days, his parents had to grapple with the haunting question: Why? Because of a study ...
Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results